Chronic hepatitis B virus (HBV) infection progresses through distinct disease phases that are
strongly associated with patient age. The so-called immune tolerant (IT) phase represents …

Objectives. A systematic review of parental surveys about HPV and/or child HPV vaccination
to understand parental knowledge, attitudes, and behaviour before and after FDA approval …

Background Despite the existence of effective prevention and treatment interventions,
hepatitis B virus (HBV) infection continues to cause nearly 1 million deaths each year. WHO …

Abstract In 2016 the World Health Organization set the goal of eliminating hepatitis B
globally by 2030. Horizontal transmission has been greatly reduced in most countries by …

The statistical data for Israel are supplied by and under the responsibility of the relevant
Israeli authorities. The use of such data by the OECD is without prejudice to the status of the …

Immunity is not static but varies with age. The immune system of a newborn infant is not
“defective” or “immature.” Rather, there are distinct features of innate and adaptive immunity …

Objective To review the epidemiology, natural history, evaluation, and treatment of hepatitis
B virus (HBV) infection during pregnancy. This will aid obstetric care providers in counseling …

Prevention of hepatitis B virus (HBV) infection with its consequent development of HBV
chronic liver disease and hepatocellular carcinoma is a global mandatory goal. Fortunately …

Hepatitis B virus (HBV) has been considered to be a “stealth virus” that induces negligible
innate immune responses during the early phase of infection. However, recent studies with …

Background: The duration of protection following primary series vaccination against hepatitis
B is unknown in children and adolescents. It has been shown that the level of anti-hepatitis B …